Peggy Schrammel

Peggy Schrammel has a wealth of experience in the healthcare and pharmaceutical industry. Starting in 1993, they worked as a Research Specialist at the University of Pittsburgh Medical Center. Peggy then joined Covance as a Senior Associate from 1996 to 1998.

In 1998, Schrammel became a Senior Manager at The Lewin Group, where they worked until 2000. Peggy then joined Quintiles as Vice President of Late Phase Operations from 2000 to 2001. Peggy later served as Vice President of Strategy and Development at Quintiles from 2001 to 2004.

From 2004 to 2008, Schrammel worked at PharmaNet as Vice President of Patient Registries and Post Approval Studies. Peggy then moved on to United BioSource Corporation as Vice President of Patient Registries and Post Approval Development from 2009 to 2011.

Schrammel joined PAREXEL in 2011, where they held two roles: VP of Portfolio Management and Project Leadership from 2011 to 2015, and VP of Asia Pacific and Scientific Affairs from 2015 to 2017.

In 2018, they became the Senior Vice President at Lotus Clinical Research, LLC, a position they held until September 2019. Peggy currently works at Cytel in Strategic Account Management, starting in December 2019.

Overall, Schrammel has demonstrated their expertise in various areas of the healthcare and pharmaceutical industry throughout their career.

Peggy Schrammel completed their education at the University of Pittsburgh. Peggy obtained a Bachelor's degree in Western European Political Science from 1989 to 1992. Following that, they pursued a Master's degree in Public Policy from 1992 to 1995. Prior to their higher education, Peggy attended Purchase Line HS, although the duration and field of study are unknown.